PACTR201708002405365已完成未知
Efficacy of simvastatin in treating patients with traumatic brain injury.
Faculty of medicine El minia university0 个研究点目标入组 40 人开始时间: 2017年7月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Year(s) 至 60 Year(s)（—）
- 性别
- All
入选标准
- •acute Traumatic brain injury
- •age range from 18 to 60 years
- •admitted to Intensive care unit within 24 hours
排除标准
- •history of allergy to statins
- •patients with major organ dysfunction (renal, liver, cardiovascular)
- •drug or alcohol abuse
- •pregnancy or lactation
- •life threatening multiple trauma
- •administration of fibrates, niacin, or corticosteroid drugs
- •psychiatric disorder
- •past history of neurological illness, prolonged Q-T interval
- •expected to die imminently (< 24 hours)
- •signs of brain stem failure.
研究者
相似试验
招募中
2 期
Effect of simvastatin in treatment of pachyonychia congenitaIRCT20160320027109N3Shahid Beheshti University of Medical Sciences20
招募中
不适用
Effect of Simvastatin in Treatment of Uterine LeiomyomaIRCT20080831001141N34Royan Institute60
进行中（未招募）
不适用
Safety and efficacy of the addition of simvastatin to panitumumab in k-ras mutant advanced or metastatic colorectal cancer patients.A single-arm, multicenter, phase II study using a Simon two stage design. - RASTAT-PEUCTR2009-014452-30-NLAcademisch ziekenhuis Leiden acting under the name of Leids Universitair Medisch Centrum
进行中（未招募）
不适用
Safety and efficacy of the addition of simvastatin to cetuximab in k-ras mutant advanced or metastatic colorectal cancer patients.A single-arm, multicenter, phase II study using a Simon two stage design. - RASTAT-Ck-ras mutant advanced or metastatic colorectal cancer failing prior 5-FU, oxaliplatin, and irinotecan containing regimens.MedDRA version: 12.1Level: LLTClassification code 10061451Term: Colorectal cancerEUCTR2009-017384-42-NLAcademisch ziekenhuis Leiden acting under the name of Leids Universitair Medisch Centrum
已完成
2 期
Safety and efficacy of the addition of simvastatin to cetuximab in k-ras mutant advanced or metastatic colorectal cancer patients. A single-arm, multicenter, phase II study using a Simon two stage design.colorectal cancerNL-OMON35030eids Universitair Medisch Centrum46